Device Trial Radar · NCT04577053
PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics
Last checked: Nov 20, 2026Latest source record: Apr 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
20
Actual
Start
Oct 7, 2020
Primary completion
Dec 4, 2020
Study completion Sep 28, 2021
Sponsor
- Lead sponsor
- Kasey PhiferAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 6, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 14 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Overview PEMF Therapy for relief or reduction of lingering symptoms after antibiotic treatment of Lyme disease of participants in the UK. Symptoms monitored: Muscle ache, myalgia, muscle pain that is acutely located and/or 'wandering' (different location on different days) Aching joints Headache Fatigue, general tiredness, loss of energy, general exhaustion Mild, recurrent fever and/or chills occurring regularly Lack of oxygen in blood, feelings of 'air hunger', too high carbon dioxide levels in blood
Conditions
- Lyme Disease
- Lyme Neuroborreliosis
- Lyme Arthritis
- Unknown Origin Fever
Interventions
Scientific Consciousness Interface Operations (SCIO) Class II FDA approved medical deviceDevice
Manufactured by QX World Ltd. in Budapest, Hungary
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Energy LevelsTime frame: 18 months
- MyalgiaTime frame: 18 months
- Joint stiffnessTime frame: 18 months
2 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
The Bristol Centre for Biofeedback
Bristol, United Kingdom
The National Centre for Electromagnetic Therapies CIC
Weston, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.